{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidj7k37e4yrb66pibjbnllo4waasycluemzgebu7aaen7gsgq7uxy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnxf2rcyrvd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid5k4i7abgny54wzm3lw3mym2vexadcijihfdw4ipa35hea3kmyde"
    },
    "mimeType": "image/jpeg",
    "size": 460063
  },
  "path": "/news/2026-06-ultrasensitive-blood-neck-cancer-relapse.html",
  "publishedAt": "2026-06-10T14:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after surgery and may benefit the most from additional treatments. The results are published in Science Translational Medicine.",
  "title": "Ultrasensitive blood test predicts head and neck cancer relapse months earlier"
}